• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奎尼丁和美西律对心室不应期适应心率增加的影响。

The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.

作者信息

Rosenheck S, Schmaltz S, Kadish A H, Summitt J, Morady F

机构信息

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109.

出版信息

Am Heart J. 1991 Feb;121(2 Pt 1):512-7. doi: 10.1016/0002-8703(91)90719-x.

DOI:10.1016/0002-8703(91)90719-x
PMID:1990756
Abstract

The purpose of this study was to determine the effects of quinidine and mexiletine on the adaptation of ventricular refractoriness to a change in heart rate. The ventricular effective refractory period was measured at a basic drive cycle length of 500 msec with basic drive train durations of two beats, eight beats, 20 beats and 3 minutes. The ventricular refractory periods were measured in the baseline state and after oral treatment with quinidine or mexiletine in 20 subjects each. In the baseline state, there was progressive shortening of the ventricular refractory period as the drive train duration increased from two beats to 3 minutes. Quinidine prolonged refractoriness by 5% (p less than 0.001) at each drive train duration. Mexiletine did not affect the ventricular effective refractory period at any of the drive train durations. In a control group of 20 subjects, there were no significant differences between two determinations of refractoriness at each basic drive train duration. In conclusion, neither quinidine nor mexiletine affect the adaptation of ventricular refractoriness to an increase in rate. Although the ventricular effective refractory period measured with a conventional basic drive train duration of eight beats is often more than 20 msec longer than the actual ventricular effective refractory period measured with a drive train duration of 3 minutes, the effects of quinidine and mexiletine on the conventionally measured ventricular effective refractory period accurately reflect the effects of these drugs on the actual ventricular effective refractory period.

摘要

本研究的目的是确定奎尼丁和美西律对心室不应期适应心率变化的影响。在基础驱动周期长度为500毫秒、基础驱动序列持续时间分别为两个搏动、八个搏动、20个搏动和3分钟的情况下测量心室有效不应期。在20名受试者中,分别在基线状态以及口服奎尼丁或美西律后测量心室不应期。在基线状态下,随着驱动序列持续时间从两个搏动增加到3分钟,心室不应期逐渐缩短。在每个驱动序列持续时间下,奎尼丁使不应期延长5%(p<0.001)。在任何驱动序列持续时间下,美西律均不影响心室有效不应期。在一个由20名受试者组成的对照组中,在每个基础驱动序列持续时间下的两次不应期测定之间无显著差异。总之,奎尼丁和美西律均不影响心室不应期对心率增加的适应性。尽管采用传统的八个搏动的基础驱动序列持续时间测量的心室有效不应期通常比采用3分钟的驱动序列持续时间测量的实际心室有效不应期长20毫秒以上,但奎尼丁和美西律对传统测量的心室有效不应期的影响准确反映了这些药物对实际心室有效不应期的影响。

相似文献

1
The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.奎尼丁和美西律对心室不应期适应心率增加的影响。
Am Heart J. 1991 Feb;121(2 Pt 1):512-7. doi: 10.1016/0002-8703(91)90719-x.
2
The effect of rate on prolongation of ventricular refractoriness by quinidine in humans.奎尼丁对人体心室不应期延长的速率影响。
Pacing Clin Electrophysiol. 1990 Nov;13(11 Pt 1):1379-84. doi: 10.1111/j.1540-8159.1990.tb04012.x.
3
The maximum effect of an increase in rate on human ventricular refractoriness.
Pacing Clin Electrophysiol. 1988 Dec;11(12):2223-34. doi: 10.1111/j.1540-8159.1988.tb05989.x.
4
Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.频率依赖性抗心律失常药物对犬活体心室肌复极后不应期和心室传导时间的影响
J Pharmacol Exp Ther. 1989 Oct;251(1):39-46.
5
Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.美西律 - 奎尼丁联合用药:人体中有利抗心律失常相互作用的电生理关联
J Am Coll Cardiol. 1987 Nov;10(5):1149-56. doi: 10.1016/s0735-1097(87)80360-1.
6
Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.当奎尼丁单一疗法失败时,通过程序电刺激评估口服奎尼丁 - 美西律联合疗法对持续性室性心律失常的有效性。
Am Heart J. 1994 Apr;127(4 Pt 1):847-51.
7
Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.奎尼丁、美西律及其组合对体内复极后不应期的频率依赖性效应。
J Cardiovasc Pharmacol. 1989 Dec;14(6):810-7. doi: 10.1097/00005344-198912000-00003.
8
Electropharmacologic synergism with mexiletine and quinidine.与美西律和奎尼丁的电药理学协同作用。
J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):840-6. doi: 10.1097/00005344-198709010-00028.
9
Effect of sudden rate acceleration on the human His-Purkinje system: adaptation of refractoriness in a dampened oscillatory pattern.
Circulation. 1986 May;73(5):920-9. doi: 10.1161/01.cir.73.5.920.
10
Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.奎尼丁在美西律 - 奎尼丁相互作用中的作用:抗心律失常疗效增强的电生理相关性。
J Cardiovasc Pharmacol. 1990 Nov;16(5):685-92. doi: 10.1097/00005344-199011000-00001.

引用本文的文献

1
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review.美西律治疗(复发性)室性心律失常高危患者的有效性和安全性:系统评价。
Europace. 2022 Nov 22;24(11):1809-1823. doi: 10.1093/europace/euac087.
2
Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model.难治性弥散促进 Scn5a(+/-) 小鼠模型中的传导障碍和心律失常。
Pflugers Arch. 2011 Oct;462(4):495-504. doi: 10.1007/s00424-011-0989-3. Epub 2011 Jul 21.